Why pharma’s digital health tools miss the mark
Explore the cultural, operational, and value-definition shifts required for digital health to deliver durable impact.
Newsletters and Deep Dive digital magazine
Explore the cultural, operational, and value-definition shifts required for digital health to deliver durable impact.
New hospital-level analysis shows a provider landscape that is more concentrated, regionally uneven & strategically complex than commercially assumed.
Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, discusses barriers and the breakthroughs in making AI work.
The development experience with GLP-1 analogues offers critical insights for navigating ADME challenges in contemporary peptide programmes.
Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden.
Editor's Picks
Newsletters and Deep Dive
digital magazine